161 related articles for article (PubMed ID: 12956398)
1. Effect of sarpogrelate on altered STZ-diabetes induced cardiovascular responses to 5-hydroxytryptamine in rats.
Umrani DN; Bodiwala DN; Goyal RK
Mol Cell Biochem; 2003 Jul; 249(1-2):53-7. PubMed ID: 12956398
[TBL] [Abstract][Full Text] [Related]
2. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
[TBL] [Abstract][Full Text] [Related]
3. Influence of 5-hydroxytryptamine and the effect of a new serotonin receptor antagonist (sarpogrelate) on detrusor smooth muscle of streptozotocin-induced diabetes mellitus in the rat.
Kodama M; Takimoto Y
Int J Urol; 2000 Jun; 7(6):231-5. PubMed ID: 10843455
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of sarpogrelate action in improving cardiac function in diabetes.
Goyal RK; Elimban V; Xu YJ; Kumamoto H; Takeda N; Dhalla NS
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):380-7. PubMed ID: 21183729
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats.
Sevak AR; Goyal RK
Pharmacol Res; 1996; 34(5-6):201-9. PubMed ID: 9076844
[TBL] [Abstract][Full Text] [Related]
6. Serotonin potentiates high-glucose-induced endothelial injury: the role of serotonin and 5-HT(2A) receptors in promoting thrombosis in diabetes.
Yamada K; Niki H; Nagai H; Nishikawa M; Nakagawa H
J Pharmacol Sci; 2012; 119(3):243-50. PubMed ID: 22785018
[TBL] [Abstract][Full Text] [Related]
7. Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.
Kim DH; Choi BH; Ku SK; Park JH; Oh E; Kwak MK
PLoS One; 2016; 11(4):e0153965. PubMed ID: 27097221
[TBL] [Abstract][Full Text] [Related]
8. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R
Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591
[TBL] [Abstract][Full Text] [Related]
9. Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats.
Fernández-González JF; García-Pedraza JÁ; Marín-Quílez A; Bastida JM; Martín ML; Morán A; García-Domingo M
Biomed Pharmacother; 2022 Sep; 153():113276. PubMed ID: 35717784
[TBL] [Abstract][Full Text] [Related]
10. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
García-Pedraza JÁ; García M; Martín ML; Gómez-Escudero J; Rodríguez-Barbero A; Román LS; Morán A
Eur J Pharmacol; 2013 Aug; 714(1-3):65-73. PubMed ID: 23769743
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic activity of sarpogrelate and dopamine D
Fouad Shalaby MA; Abd El Latif HA; El Yamani M; Galal MA; Kamal S; Sindi I; Masaood R
BMC Pharmacol Toxicol; 2021 Oct; 22(1):64. PubMed ID: 34702339
[TBL] [Abstract][Full Text] [Related]
12. Changes in serotonin levels and 5-HT receptor activity in duodenum of streptozotocin-diabetic rats.
Takahara H; Fujimura M; Taniguchi S; Hayashi N; Nakamura T; Fujimiya M
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G798-808. PubMed ID: 11518692
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic ramipril treatment in streptozotocin-induced diabetic rats.
Hakim ZS; Patel BK; Goyal RK
Indian J Physiol Pharmacol; 1997 Oct; 41(4):353-60. PubMed ID: 10235657
[TBL] [Abstract][Full Text] [Related]
14. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
15. Effect of sarpogrelate hydrochloride, a 5-HT2 blocker, on insulin resistance in Otsuka Long-Evans Tokushima fatty rats (OLETF rats), a type 2 diabetic rat model.
Takishita E; Takahashi A; Harada N; Yamato M; Yoshizumi M; Nakaya Y
J Cardiovasc Pharmacol; 2004 Feb; 43(2):266-70. PubMed ID: 14716215
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats.
Bhadada SV; Goyal RK
Can J Physiol Pharmacol; 2007 Aug; 85(8):831-6. PubMed ID: 17901894
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
Hakim ZS; Goyal RK
Indian J Physiol Pharmacol; 2000 Apr; 44(2):125-35. PubMed ID: 10846625
[TBL] [Abstract][Full Text] [Related]
18. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
19. Selective blockade of serotonin 5-HT2A receptor increases coronary blood flow via augmented cardiac nitric oxide release through 5-HT1B receptor in hypoperfused canine hearts.
Fujita M; Minamino T; Sanada S; Asanuma H; Hirata A; Ogita H; Okada K; Tsukamoto O; Takashima S; Tomoike H; Node K; Hori M; Kitakaze M
J Mol Cell Cardiol; 2004 Dec; 37(6):1219-23. PubMed ID: 15572052
[TBL] [Abstract][Full Text] [Related]
20. Blockade of 5-HT(2A) receptors by sarpogrelate protects the heart against myocardial infarction in rats.
Brasil D; Temsah RM; Kumar K; Kumamoto H; Takeda N; Dhalla NS
J Cardiovasc Pharmacol Ther; 2002 Jan; 7(1):53-9. PubMed ID: 12000979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
